- Home
- SLNHP vs INM Comparison
SLNHP vs INM Comparison
Compare SLNHP & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNHP | INM |
|---|---|---|
| Founded | N/A | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 7.1M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLNHP | INM |
|---|---|---|
| Price | $12.82 | $1.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.0K | ★ 59.7K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.41 | 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $38,021,000.00 | $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 80.49 | 7.50 |
| 52 Week Low | $6.30 | $0.58 |
| 52 Week High | $12.85 | $2.50 |
Technical Indicators
Market Signals| Indicator | SLNHP | INM |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 50.74 |
| Support Level | $8.52 | $1.35 |
| Resistance Level | N/A | $1.40 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 98.03 | 54.88 |
Price Performance
Historical ComparisonAbout SLNHP Soluna Holdings Inc 9.0% Series A Cumulative Perpetual Preferred Stock
Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.